Insight

Patrick Hwu: This study demonstrates the importance of vaccine route when designing cancer immunotherapies

Photo taken from Patrick Hwu/X

Mar 25, 2024, 12:39

Patrick Hwu: This study demonstrates the importance of vaccine route when designing cancer immunotherapies

Patrick Hwu, President and CEO at Moffitt Cancer Center, posted on X/Twitter:

“For cancer vaccines to be effective, they need to generate tumor reactive T cells capable of migrating into tissues. Does vaccine route of administration matter? In this study, investigators found that intranasal (mucosal) vaccination resulted in T cells that were capable of infiltrating lung tissue compared to intramuscular vaccination. The mucosal vaccine decreased lung metastases in a murine breast cancer model. The effects were enhanced when the vaccine also encoded IL-1 beta and combined with radiation. This study demonstrates the importance of vaccine route when designing cancer immunotherapies.

Here’s a link to the full article.”

Source: Patrick Hwu/X

Breast Cancer cancer IL-1 beta immunotherapies mucosal vaccine murine breast cancer model OncoDaily Oncology Patrick Hwu tumor reactive T cells vaccine

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage